Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2025 / September / Wilson Disease Steatosis Diet Versus Copper
Molecular Pathology Clinical care

Wilson Disease Steatosis: Diet Versus Copper

Copper, ceruloplasmin, and fibrosis pathways mapped in patients and knockout mice reveal diagnostic insights for Wilson disease

By Kathryn Wighton 09/22/2025 News 2 min read

Share

In Wilson disease (WD), fatty liver was linked to cardiometabolic risk, and in ATP7B-knockout mice, a high-fat diet – not copper overload – drove steatohepatitis and fibrosis, according to a recent study.

Researchers examined hepatic steatosis in WD in a retrospective cohort and in a mouse model focusing on diet and metabolic risk. Among 61 hospitalized adults with WD, 12 percent had imaging or histologic steatosis. All patients with steatosis had at least one cardiometabolic risk factor, and body mass index was higher compared with patients without steatosis (26 ± 2.0 kg/m² versus 23 ± 0.6 kg/m²; P = 0.039). Copper measures and liver enzymes did not differ meaningfully by steatosis status. In an age- and sex-matched comparison with 122 patients with metabolic dysfunction–associated steatotic liver disease, the metabolic dysfunction group had higher blood pressure, body mass index, fasting glucose, hemoglobin A1c, Homeostasis Model Assessment of Insulin Resistance scores, triglycerides, low-density lipoprotein, and alanine aminotransferase, whereas the WD group had higher alkaline phosphatase and total bilirubin and lower albumin.

Using CRISPR/Cas9, the study, publihsed in The American Journal of Pathology, generated ATP7B knockout (KO) mice. On chow through 40 weeks, KO mice showed hepatic copper accumulation, increased 24-hour urinary copper, and reduced plasma ceruloplasmin activity without spontaneous liver injury or neurologic deficits. Under physiological conditions, KO mice had lower plasma and hepatic triglyceride and cholesterol versus wild type; liver-directed adeno-associated viral ATP7B expression partially increased lipid measures.

With 24 weeks of high-fat diet (HFD), steatohepatitis occurred in both genotypes. KO mice had higher steatosis scores, higher hepatic triglyceride and plasma cholesterol, and higher aspartate aminotransferase versus wild type. Masson staining and α–smooth muscle actin immunohistochemistry showed more fibrosis in KO mice. Hepatic transcripts related to inflammation and fibrogenesis were increased. Transcriptomic analyses in KO livers on HFD showed enrichment of extracellular matrix organization, angiogenesis, apoptosis, and inflammatory pathways. In KO mice, HFD was associated with lower hepatic copper and higher plasma copper and ceruloplasmin activity; similar directions were observed in wild type without statistical significance. The study noted that these shifts involve components of the Leipzig scoring system used for WD assessment.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Kathryn Wighton

Editor, Conexiant

More Articles by Kathryn Wighton

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Redefining Diagnostic Reference Standards
Molecular Pathology
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Non-invasive Prostate Cancer Screening
Molecular Pathology
Non-invasive Prostate Cancer Screening

November 5, 2014

1 min read

Can SERS accurately detect the early stages of the most common male cancer?

Sequencing Access for All
Molecular Pathology
Sequencing Access for All

January 24, 2022

1 min read

An affordable genome sequencing pipeline for low- and middle-income countries

Improving Risk Stratification
Molecular Pathology
Improving Risk Stratification

February 3, 2022

1 min read

Two genes have been identified that may be linked to prostate cancer outcomes

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.